Life Sciences Talk
Welcome to Life Sciences Talk, our blog dedicated to innovation in the health and healthcare sector.
Here our global network of life sciences experts will share their views and insights on the latest developments in the industry. They'll comment on and analyse topics including pharmaceuticals, digital health, medical devices, biotech, IP and life sciences regulatory issues around the world.
Subscribe to the blog, share our insights with your network, and join the conversation.
Subscribe to the blog, share our insights with your network, and join the conversation.
Featured posts
Blog Post: 21 November 2023
The UK Competition and Markets Authority (CMA) has taken the unusual step of issuing a prioritisation statement on cooperation between competitors to make combination therapies available to the NHS.
Read more UK CMA issues 'prioritisation statement' to allay competition law fears that prevent combination therapies reaching NHS
Blog Post: 23 October 2023
The European Commission (EC) has fined five pharmaceutical companies a total of EUR13.4 million for participating in a cartel concerning N-Butylbromide Scopolamine/Hyoscine (SNBB) – an active…
Read more European Commission sanctions first ever pharmaceuticals cartel and scores victory in pay-for-delay appeal
All posts
